Vlad Popovic

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial

Timo Vesikari, Joanne M. Langley, Nathan Segall et al. · The Lancet Infectious Diseases · 2021 · 72 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine

Timo Vesikari, Adam Finn, Pierre Van Damme et al. · JAMA Network Open · 2021 · 61 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Onset of Maximum Neuromuscular Block Following Succinylcholine or Vecuronium in Four Age Groups

Zbigniew J. Koscielniak-Nielsen, Joan C. Bevan, Vlad Popovic et al. · Anesthesiology · 1993 · 47 citations · Full text

Medicine, Anesthesiology, Pharmacology +12

Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study

Jacob Atsmon, Nathalie Machluf, Vered Yayon-gur et al. · Vaccine · 2021 · 12 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trial

Francisco Díaz‐Mitoma, Vlad Popovic, Johanna N. Spaans · Vaccine · 2021 · 12 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17